Erste Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $845K | Hold |
52,500
| – | – | 0.01% | 534 |
|
|
2025
Q1 | $964K | Hold |
52,500
| – | – | 0.01% | 380 |
|
|
2024
Q4 | $1.29M | Hold |
52,500
| – | – | 0.02% | 362 |
|
|
2024
Q3 | $1.47M | Buy |
52,500
+7,000
| +15% | +$196K | 0.02% | 352 |
|
|
2024
Q2 | $1.18M | Hold |
45,500
| – | – | 0.02% | 356 |
|
|
2024
Q1 | $1.48M | Hold |
45,500
| – | – | 0.02% | 331 |
|
|
2023
Q4 | $1.93M | Buy |
+45,500
| New | +$1.93M | 0.03% | 298 |
|